StockWatch
·
Pharmaceuticals
Promoter Reclassification28 Sept 2026, 09:13 pm

Bliss GVS Pharma: Anupam Rasayan & PAC Acquire Control, New Directors Appointed

AI Summary

Bliss GVS Pharma Ltd announced the outcome of its Board Meeting held on September 28, 2026. The meeting confirmed the change in control and promoter status, with Anupam Rasayan India Limited and Mates Visa Consultancy Private Limited (PAC) collectively acquiring 47.95% of the equity share capital. This acquisition makes them the new promoters of the company. Additionally, the board approved the appointment of Mr. Hetul Krishnakant Mehta, Mr. Amar Dilip Shah, and Mr. Pramod Badrinarayan Kasat as Additional Directors. The resignation of Mr. Narsimha Shibroor Kamath from the position of Managing Director was also noted. A postal ballot notice for the appointment of the new directors was approved.

Key Highlights

  • Anupam Rasayan and PAC now control Bliss GVS Pharma with 47.95% stake.
  • New promoters appointed as per SEBI regulations.
  • Three new Non-Executive Non-Independent Directors appointed.
  • Managing Director Mr. Narsimha Kamath has resigned.
  • Postal ballot notice approved for director appointments.